The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J. J.
Right arrow Articles by Russell, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J. J.
Right arrow Articles by Russell, J. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOSPORIN A
The Journal of Immunology, 2003, 171: 6112-6118.
Copyright © 2003 by The American Association of Immunologists

Regulation and Phenotype of an Innate Th1 Cell: Role of Cytokines and the p38 Kinase Pathway 1

Jeffrey J. Yu{dagger}, Catherine S. Tripp2,3,* and John H. Russell2,4,{dagger}

* Department of Arthritis and Inflammation Pharmacology, Pharmacia Corporation, St. Louis, MO 63198; and {dagger} Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110

We have explored the phenotype and regulation of Th1 cell activation by the cytokines IL-12 and IL-18. We demonstrate that these two cytokines selectively induce IFN-{gamma} in a differentiated Th1 cell population through the previously described p38 mitogen-activated protein (MAP) kinase pathway. Using a highly selective p38 MAP kinase inhibitor, we demonstrate that it is possible to block IFN-{gamma} induction from activated, differentiated Th1 cells via p38 MAP kinase without disrupting the activation and differentiation of naive T cells or the proliferation of naive or differentiated T cells. In addition, IL-12 and IL-18 provide an Ag and IL-2-independent survival signal to this uniquely differentiated Th1 cell population. We hypothesize that this Ag-independent survival of Th1 cells may participate in an innate inflammatory loop with monocytes at the sites of chronic inflammation. In addition, p38 MAP kinase inhibition of this cytokine-regulated pathway may be a unique mechanism to inhibit chronic inflammation without disruption of Ag-driven activation and function of naive T cells.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Li, I. H. Chaudry, and M. A. Choudhry
ERK and Not p38 Pathway Is Required for IL-12 Restoration of T Cell IL-2 and IFN-{gamma} in a Rodent Model of Alcohol Intoxication and Burn Injury
J. Immunol., September 15, 2009; 183(6): 3955 - 3962.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Jirmanova, D. N. Sarma, D. Jankovic, P. R. Mittelstadt, and J. D. Ashwell
Genetic disruption of p38{alpha} Tyr323 phosphorylation prevents T-cell receptor-mediated p38{alpha} activation and impairs interferon-{gamma} production
Blood, March 5, 2009; 113(10): 2229 - 2237.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sattler, U. Wagner, M. Rossol, J. Sieper, P. Wu, A. Krause, W. A. Schmidt, S. Radmer, S. Kohler, C. Romagnani, et al.
Cytokine-induced human IFN-{gamma}-secreting effector-memory Th cells in chronic autoimmune inflammation
Blood, February 26, 2009; 113(9): 1948 - 1956.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. R. Lees, P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell
Regional CNS responses to IFN-{gamma} determine lesion localization patterns during EAE pathogenesis
J. Exp. Med., October 27, 2008; 205(11): 2633 - 2642.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Lees, Y. Iwakura, and J. H. Russell
Host T Cells Are the Main Producers of IL-17 within the Central Nervous System during Initiation of Experimental Autoimmune Encephalomyelitis Induced by Adoptive Transfer of Th1 Cell Lines
J. Immunol., June 15, 2008; 180(12): 8066 - 8072.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Jirmanova, D. Jankovic, A. J. Fornace Jr., and J. D. Ashwell
Gadd45{alpha} Regulates p38-Dependent Dendritic Cell Cytokine Production and Th1 Differentiation
J. Immunol., April 1, 2007; 178(7): 4153 - 4158.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Zhang, W. Kim, L. Zhou, N. Wang, L. H. Ly, D. N. McMurray, and R. S. Chapkin
Dietary Fish Oil Inhibits Antigen-Specific Murine Th1 Cell Development by Suppression of Clonal Expansion
J. Nutr., September 1, 2006; 136(9): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Maxwell, R. Yadav, R. J. Rossi, C. E. Ruby, A. D. Weinberg, H. L. Aguila, and A. T. Vella
IL-18 Bridges Innate and Adaptive Immunity through IFN-{gamma} and the CD134 Pathway
J. Immunol., July 1, 2006; 177(1): 234 - 245.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. S. Berenson, J. Yang, B. P. Sleckman, T. L. Murphy, and K. M. Murphy
Selective Requirement of p38{alpha} MAPK in Cytokine-Dependent, but Not Antigen Receptor-Dependent, Th1 Responses.
J. Immunol., April 15, 2006; 176(8): 4616 - 4621.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Canfield, Y. Lee, A. Schroder, and P. Rothman
Cutting Edge: IL-4 Induces Suppressor of Cytokine Signaling-3 Expression in B Cells by a Mechanism Dependent on Activation of p38 MAPK
J. Immunol., March 1, 2005; 174(5): 2494 - 2498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. McKarns and R. H. Schwartz
Distinct Effects of TGF-{beta}1 on CD4+ and CD8+ T Cell Survival, Division, and IL-2 Production: A Role for T Cell Intrinsic Smad3
J. Immunol., February 15, 2005; 174(4): 2071 - 2083.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Mavropoulos, G. Sully, A. P. Cope, and A. R. Clark
Stabilization of IFN-{gamma} mRNA by MAPK p38 in IL-12- and IL-18-stimulated human NK cells
Blood, January 1, 2005; 105(1): 282 - 288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.